Skip to main content
. 2016 Aug 17;9:71. doi: 10.1186/s13045-016-0301-2

Fig. 2.

Fig. 2

Cumulative incidence of neutrophil engraftment and platelet engraftment. Left panel: cumulative incidence of neutrophil engraftment in plerixafor-treated patients (solid line) and control patients (dashed line). Right panel: cumulative incidence of platelet engraftment in plerixafor-treated patients (solid line) and contemporaneous control patients (dashed line). Excluding the two bone marrow recipients